Norwood Abbey & AWI JV to develop needle-free delivery system
26 Aug '05
3 min read
Melbourne based Norwood Abbey Limited announced that it has entered into an agreement with Australian Wool Innovation Limited (AWI) for the next phase of development of its needle-free delivery system to deliver a chemical mulesing agent (protein) into sheep.
The agreement relates to the Phase II development and testing of the device which is designed to deliver substances by way of an application technology that can effectively substitute for surgical mulesing.
AWI is funding the Phase II development project.
The Phase II development project will develop a needle-free injector for drug delivery and has two main stages:
-- The first stage will develop a needle-free injector for administering the mulesing protein
-- The second stage will test this injector on live sheep (this is in addition to studies already successfully completed)
The first stage is complete. The second stage of the program will involve testing of the prototype device in sheep and is scheduled to commence in September 2005. Ethics approval for this second stage of testing has been granted.
As previously reported the Bioinstrumentation Laboratory at Massachusetts Institute of Technology in Boston (MIT) has produced the first hand-held working prototype of a needle-free drug delivery device. In recent trials at MIT, the prototype device has successfully delivered the protein into sheep skin in the laboratory. Additionally, in preliminary trials on sheep, the hand-held prototype device delivered the protein to an animal. Based on the trial parameters and examination of biopsied skin samples, the trial was deemed to be a success.
marketing@alchempro.com
